Liver transplant results for hepatocellular carcinoma applying strict preoperative selection criteria.
BACKGROUND
Liver transplantation is currently the best therapeutic option for small hepatocellular carcinoma (HC) in selected cirrhotic patients. The main aim of this study was to analyze the results of a recent series of liver transplant cirrhotic patients with small HC applying strict preoperative selection criteria.


METHODS
During a period of 6 years we performed 53 liver transplants with a final diagnosis of HC on cirrhosis. The selection criteria for liver transplantation (LT) by modern imaging techniques were the Milan criteria (TNM I and II of the modified classification).


RESULTS
Of the 53 patients, 44 (83%) were transplanted with preoperatively known HC, and 9 (17%) with incidental HC. The mean time on the waiting list was 74 +/- 62 days. Despite using strict selection criteria, 23 patients (43%) exceeded the Milan criteria in the specimen and 17 (32%) even exceeded the extended criteria of the UCSF. With a mean follow-up of 2 years, only two patients have developed recurrences. The overall survival at 1, 3, and 5 years was 80%, 70%, and 70%, respectively. The survival of patients that exceeded the Milan or USF criteria at 1, 3, and 5 years was 72% and 76%; 67% and 69%; 67% and 69%, respectively.


CONCLUSIONS
The results of liver transplantation for HC are excellent when applying strict preoperative selection criteria. The current imaging methods lead to a considerable infrastaging percentage (30% to 40%), extending the indications for liver transplant due to HC beyond the scope that clinical reports would justify.
Santoyo
J
J
Hepatobiliary Surgery and Liver Transplant Unit, General and Digestive Surgery Department, Hospital Regional Universitario Carlos Haya, Malaga, Spain. jsantoyo@telefonica.net
Suarez
M A
MA
Fernández-Aguilar
J L
JL
Jiménez
M
M
Perez Daga
J A
JA
Sánchez-Perez
B
B
Gonzalez Poveda
I
I
Gonzalez-Sanchez
A
A
Ramírez
C
C
de la Fuente
A
A
D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D004621:Embolization, Therapeutic; D000431:Ethanol / Q000627:therapeutic use; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D016031:Liver Transplantation / Q000401:mortality / Q000502:physiology*; D009367:Neoplasm Staging; D018579:Patient Selection; D011300:Preoperative Care; D011846:Radio Waves; D012008:Recurrence; D016019:Survival Analysis
D000431:Ethanol